The eRNA-related agents in cancer have been previously reviewed, including bromodomain and extra-terminal (BET) inhibitors, cyclin-dependent kinases (CDKs), HAT inhibitors and HDAC inhibitors (33, 34, 177). The gene discussed is HDAC9; the disease is cancer.